Compare Amazon.com Inc (AMZN) vs Vertex Pharmaceuticals Incorporated (VRTX) Price & Performance

Amazon (AMZN) trades at $278.09, up 1.32% with strong bullish momentum as technical indicators show the stock above key support levels. The company demonstrates robust fundamentals with revenue growing to $716.92 billion in 2025 and net income reaching $77.67 billion, representing a 10.83% margin. Recent earnings beats in Q1 and Q2 2026 exceeded expectations significantly, while analyst sentiment remains overwhelmingly positive with 89% buy ratings.

Amazon's outlook remains favorable with continued revenue growth projected to $775.7 billion in 2026 and expanding profit margins. The primary investment opportunity lies in AWS growth and AI chip development, though risks include intense competition in e-commerce and significant capital expenditures. With a consensus price target of $333.86 representing 20% upside potential, the stock appears positioned for continued growth despite near-term overbought technical conditions.

Vertex Pharmaceuticals (VRTX) trades at $523.91, up 5.61% with strong technical momentum and bullish moving averages. The company reported Q2 2026 revenue growth of 12% to $3.3 billion, beating expectations despite an EPS miss, and raised its full-year 2026 revenue guidance. Valuation metrics show a P/E of 30.85 and P/S of 10.78, while maintaining robust profitability with 86% gross margins and 35% net income margins.

Outlook remains positive with analyst consensus strongly bullish (84% buy ratings) and a $534.25 price target. Key risks include execution on newer product launches and competitive pressures in cystic fibrosis treatments. The stock's current momentum suggests continued upside potential, though RSI levels indicate potential near-term overbought conditions.